Meng Z D, Kennett M L, Rodger S M, Dickson K E, Anderson B N, Gust I D
J Hyg (Lond). 1986 Oct;97(2):377-83. doi: 10.1017/s0022172400065463.
Forty-one strains of adenovirus type 19/37 (Ad19/37) mainly isolated from patients with keratoconjunctivitis or conjunctivitis between 1974 and 1984 were re-evaluated by serum neutralization (SN), haemagglutination inhibition (HI) and DNA restriction analysis. Of 19 isolates which were neutralized to high titre by antiserum prepared against prototype Ad19, 5 showed cross-reactivity with 32-64 units of Ad37 antiserum, while of 22 strains neutralized by high titre by Ad37 antiserum, 3 showed cross-reactivity with 32 units of Ad19 antiserum. By DNA restriction analysis, all Ad19 isolates were identical to each other and to Ad19A virus. Using endonuclease Bgl 1, three variants were observed among the Ad37 isolates.
对1974年至1984年间主要从角结膜炎或结膜炎患者中分离出的41株19/37型腺病毒（Ad19/37），通过血清中和试验（SN）、血凝抑制试验（HI）和DNA限制性分析进行了重新评估。在19株被针对原型Ad19制备的抗血清高滴度中和的分离株中，5株与32 - 64单位的Ad37抗血清表现出交叉反应，而在22株被Ad37抗血清高滴度中和的菌株中，3株与32单位的Ad19抗血清表现出交叉反应。通过DNA限制性分析，所有Ad19分离株彼此相同，且与Ad19A病毒相同。使用内切酶Bgl 1，在Ad37分离株中观察到三个变体。
